AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Zanvia-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Vivifi Life Sciences

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Zanvia-M 50/500 Tablet

Diabex Duo 50/500 tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lessening the risk of stroke or heart attack. Diabex Duo 50/500 may be used as a standalone treatment or in conjunction with other diabetes therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health, blood sugar readings, and other medications. Consuming the tablet with food minimizes stomach upset. For maximum efficacy, take it consistently at the same time daily; discontinue only under your doctor's guidance. Adherence to your doctor's dietary and exercise plan is crucial for successful diabetes management; lifestyle choices significantly impact blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to identify and manage this risk. This medication isn't for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before starting treatment. Pregnant or lactating women should seek medical advice. Other medications may interact with Diabex Duo 50/500; disclose all medications to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your physician will monitor kidney function and blood sugar levels throughout your treatment.

Uses of Zanvia-M 50/500 Tablet

Managing Type 2 Diabetes

Major Benefits of Zanvia-M 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet; do not crush, chew, or divide it. It is recommended to take Zanvia-M 50/500 with a meal.

Common Side effects of Zanvia-M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Zanvia-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Zanvia-M 50/500 Tablet should be administered with a meal.

How Zanvia-M 50/500 Tablet works:

Zanvia-M 50/500 tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Zanvia-M 50/500 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Zanvia-M 50/500 tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against these risks prior to prescription. Consult your physician for guidance.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zanvia-M 50/500 tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Zanvia-M 50/500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, Zanvia-M 50/500 Tablets are contraindicated. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Zanvia-M 50/500 tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Zanvia-M 50/500 Tablet :

Should you forget a Zanvia-M 50/500 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zanvia-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Zanvia-M 50/500 Tablet

Zanvia-M 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is unsuitable for individuals under 18.
Prolonged Zanvia-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.
Zanvia-M 50/500 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Zanvia-M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zanvia-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Zanvia-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Zanvia-M 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zanvia-M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Zanvia-M 50/500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zanvia-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Zanvia-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged Zanvia-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Zanvia-M 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zanvia-M 50/500 Tablet may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Zanvia-M 50/500 Tablets are contraindicated in patients with hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zanvia-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Zanvia-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged Zanvia-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, along with cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Zanvia-M 50/500 Tablet
119